BBP vs. MHIP
BBP (Virtus LifeSci Biotech Products ETF) and MHIP (Milliman Healthcare Inflation Plus ETF) are both Health & Biotech Equities funds. BBP is passively managed, while MHIP is actively managed. A 0.51 correlation means they provide meaningful diversification when combined. BBP charges 0.79%/yr vs 0.55%/yr for MHIP.
Performance
BBP vs. MHIP - Performance Comparison
Loading charts...
Returns By Period
BBP
- 1D
- -0.52%
- 1M
- 11.96%
- 6M
- 21.78%
- YTD
- 22.12%
- 1Y
- 56.48%
- 3Y*
- 22.51%
- 5Y*
- 13.91%
- 10Y*
- 13.09%
MHIP
- 1D
- -0.52%
- 1M
- 1.00%
- 6M
- —
- YTD
- —
- 1Y
- —
- 3Y*
- —
- 5Y*
- —
- 10Y*
- —
BBP vs. MHIP - Yearly Performance Comparison
| 2026 (YTD) | |
|---|---|
BBP Virtus LifeSci Biotech Products ETF | 11.88% |
MHIP Milliman Healthcare Inflation Plus ETF | -0.39% |
Correlation
The correlation between BBP and MHIP is 0.51, which is moderate. They share some common price drivers but move independently often enough to provide real diversification benefit when combined.
| Correlation | |
|---|---|
Correlation (All Time) Calculated using the full available price history since Apr 21, 2026 | 0.51 |
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
BBP vs. MHIP — Risk / Return Rank
BBP
MHIP
Risk / return metrics aren't available yet — we need at least 12 months of trading data to calculate them.
BBP vs. MHIP - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Virtus LifeSci Biotech Products ETF (BBP) and Milliman Healthcare Inflation Plus ETF (MHIP). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| BBP | MHIP | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | — | — | |
| Sortino ratioReturn per unit of downside risk | — | — | |
| Omega ratioGain probability vs. loss probability | 1.38 | — | — |
| Calmar ratioReturn relative to maximum drawdown | 6.12 | — | — |
| Martin ratioReturn relative to average drawdown | 18.80 | — | — |
Loading charts...
Drawdowns
BBP vs. MHIP - Drawdown Comparison
The maximum BBP drawdown since its inception was -44.32%, which is greater than MHIP's maximum drawdown of -3.09%. Use the drawdown chart below to compare losses from any high point for BBP and MHIP.
Loading charts...
Drawdown Indicators
| BBP | MHIP | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -44.32% | -3.09% | -41.23% |
Max Drawdown (1Y)Largest decline over 1 year | -9.28% | — | — |
Max Drawdown (3Y)Largest decline over 3 years | -26.09% | — | — |
Max Drawdown (5Y)Largest decline over 5 years | -37.77% | — | — |
Max Drawdown (10Y)Largest decline over 10 years | -44.32% | — | — |
Current DrawdownCurrent decline from peak | -5.82% | -1.99% | -3.83% |
Average DrawdownAverage peak-to-trough decline | -11.93% | -1.27% | -10.66% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 3.02% | — | — |
Volatility
BBP vs. MHIP - Volatility Comparison
Loading charts...
Volatility by Period
| BBP | MHIP | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 7.46% | — | — |
Volatility (6M)Calculated over the trailing 6-month period | 19.22% | — | — |
Volatility (1Y)Calculated over the trailing 1-year period | 24.21% | 11.68% | +12.53% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 26.44% | 11.68% | +14.76% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 27.36% | 11.68% | +15.68% |
BBP vs. MHIP - Expense Ratio Comparison
BBP has a 0.79% expense ratio, which is higher than MHIP's 0.55% expense ratio.
Dividends
BBP vs. MHIP - Dividend Comparison
Neither BBP nor MHIP has paid dividends to shareholders.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
BBP Virtus LifeSci Biotech Products ETF | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.18% | 0.00% | 1.29% |
MHIP Milliman Healthcare Inflation Plus ETF | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Frequently Asked Questions
BBP and MHIP have a correlation of 0.51, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
On fees, MHIP is cheaper at 0.55% per year. The better choice depends on whether you care most about return, fees, risk, or income.
MHIP is cheaper with a 0.55% expense ratio, compared with 0.79% for BBP.
BBP and MHIP have nearly identical dividend yields, around 0.00%.
They also come from different issuers: Virtus Investment Partners and Milliman. Their fees differ too: 0.79% for BBP and 0.55% for MHIP.
Find the right allocation for BBP and MHIP
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer